Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Blueprint Medicines Corporation

http://www.blueprintmedicines.com/

Latest From Blueprint Medicines Corporation

Blueprint’s Ayvakit Mastocytosis Results Raise Commercial Uncertainty

The Phase III PIONEER study in indolent systemic mastocytosis met the primary endpoint, but the magnitude of benefit came up short of analysts’ expectations.

Cancer Business Strategies

Finance Watch: Sironax, IDRx, OriCell Reveal First VC Mega-Rounds Of August

Private Company Edition: Sironax completed a $200m series B round while IDRx launched with $122m and OriCell raised $120m in series C funds, joining end-of-July $100m-plus fundraiser Carmot Therapeutics, which closed a $160m series D financing. 

Financing StartUps and SMEs

Financing Quarterly Statistics, Q2 2022

During Q2, biopharmas brought in an aggregate $12.5bn in financing and device company fundraising totaled $3.7bn; while in vitro diagnostic firms and research tools players raised $720m.

Deals Financing

Roche Disappointed By English Funding Rejection For Gavreto But Will Not Appeal

Health technology assessment institute NICE said that uncertainty in the clinical evidence for Gavreto means that cost-effectiveness estimates are also uncertain for the drug, which is approved for treating RET fusion-positive advanced non-small cell lung cancer and is reimbursed in 10 European countries.

United Kingdom Cost Effectiveness
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
      • Molecular Diversity
  • Other Names / Subsidiaries
    • Hoyle Pharmaceuticals, Inc.
    • ImmunoCo, Inc.
UsernamePublicRestriction

Register